Android app on Google Play

Anacor (ANAC) Approves 3.25M Common Offering

February 8, 2012 4:21 PM EST Send to a Friend
Anacor Pharmaceuticals (Nasdaq: ANAC), today announced the sale of 3.25 million shares of its common stock for gross proceeds of $21,450,000 pursuant to an underwriting agreement with Canaccord Genuity acting as the sole bookrunner. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 487,500 shares of common stock to cover over-allotments, if any.




You May Also Be Interested In


Related Categories

Equity Offerings

Add Your Comment